Smaller boost volumes associated with fewer vertebral fractures after spine SBRT
In 260 vertebral metastases, GTV-based boosts showed lower Kaplan–Meier fracture estimates than segment-based boosts, but competing-risk analyses were inconclusive.
In 260 vertebral metastases, GTV-based boosts showed lower Kaplan–Meier fracture estimates than segment-based boosts, but competing-risk analyses were inconclusive.
In 376 spinal treatment sites, initial setup error was unrelated to pain severity but differed by spinal level and immobilization.
In 22 spinal targets, a dedicated planning system reduced spinal cord D2% by 2.6–2.7 Gy versus general-purpose planning without compromising PTV coverage.
After repeat spine SBRT, 12-month local failure was 6% with Dmin ≥28 Gy EQD2 versus 36% below that level.
Proton hypofractionation produced 10% one-year local failure despite extensive prior irradiation, with grade 3 toxicity confined to multiply reirradiated patients.
Seventy-three percent of failures after nonadherent sacral contouring involved sectors that guidelines recommended including in the clinical target volume.
Proton plans preserved 20-Gy target coverage while reducing spinal cord, oesophageal, lung, and bowel dose compared with photon VMAT.
Spine proton ablative radiotherapy achieved 74% local control at one and two years, with no radiation myelopathy in a reirradiation-enriched cohort.
Higher postoperative CTV minimum BED10 was associated with lower local failure after separation surgery and spine SBRT.
Carbon fiber-reinforced polyetheretherketone implants consistently reduced imaging artifacts and dosimetric uncertainty versus titanium, but clinical outcome evidence remains limited.